Modern rheumatology
Real-world safety and effectiveness of mepolizumab for patients with eosinophilic granulomatosis with polyangiitis in Japan: a subgroup analysis of the MARS study.
Tomonori Ishii, Hideaki Kunishige, Mitsuhiro Yoshida, Etsuko Hayashi, Masaki Komatsubara, Rafael Alfonso-Cristancho, Peter Howarth
Published: 202510.1093/mr/roaf096
Abstract
ObjectivesEvaluate the long-term safety and effectiveness of mepolizumab in subgroups of patients with eosinophilic granulomatosis with polyangiitis, including: disease duration, oral corticosteroid use, relapse, worsening or new-onset symptoms, anti…
Preview only. Read the full abstract at the source